SCHEMBL9955288

SCHEMBL9955288

Cc1ncc(B2OC(C)(C)C(C)(C)O2)cc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 2/20 0.52
ALPL P05186 1/20 0.45
PIK3CA P42336 7/20 0.44
SLC40A1 Q9NP59 3/20 0.44
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
BRD4 O60885 1/20 0.43
PIK3CD O00329 2/20 0.42
PIK3CB P42338 2/20 0.42
EDNRB P24530 1/20 0.40
EDNRA P25101 1/20 0.40
TSHR P16473 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3115744 0.87 PIK3CD (0.57) PIK3CGPIK3CAPIK3CDPIK3CB
SCHEMBL29555684 0.87 PIK3CD (0.57) PIK3CGPIK3CAPIK3CDPIK3CB
SCHEMBL791191 0.86 PDGFRB (0.44) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL29556839 0.85 ALPL (0.56) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL790824 0.85 ALPL (0.56) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL790432 0.83 PIK3CA (0.45) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL789981 0.83 ALPL (0.48) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL791429 0.82 ALPL (0.47) PIK3CGALPLPIK3CASLC40A1PDGFRB
SCHEMBL3514914 0.82 CA1 (0.40) ALPLPIK3CAPDGFRBKDR
SCHEMBL19297776 0.81 CA1 (0.52) ALPLPDGFRBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed